Pegues D A, Engelgau M M, Woernle C H
Division of Field Epidemiology, Centers for Disease Control and Prevention (CDC), Atlanta, GA.
Public Health Rep. 1994 Jul-Aug;109(4):530-8.
Each year, it is estimated that from 350,000 to 739,000 U.S. infants are exposed in utero to one or more illicit drugs. To estimate the prevalence of and risk factors for illicit drug use by women of childbearing age in Alabama, during 2 months in 1991 the authors collected patient-reported histories, clinical histories, and urine specimens from 6,195 women statewide attending public health maternity clinics, family planning clinics, and a high-risk referral obstetrical clinic. Blind drug screening of urine specimens for marijuana, cocaine, opiates, barbiturates, and amphetamines was performed with the use of a fluorescent polarization immunoassay. The overall prevalence of positive results for drugs tested was 10.1 percent, including 8.4 percent of the 3,554 pregnant and 12.3 percent of the 2,571 nonpregnant women screened. The drugs most frequently detected were marijuana and cocaine. Characteristics of the subjects associated with a higher prevalence of positive results for any drug tested or for marijuana included white race, older age, being divorced, non student occupation, having 12 or less years of education, attending a clinic located in a suburban county, self-reported substance use, increased risk for human immunodeficiency virus infection, and reproductive history. Characteristics of women with positive screening for cocaine results were similar to those who tested positive for any drug, except that the prevalence of cocaine was higher among black women and those attending urban county clinics and did not vary by years of education. Patient-reported histories of drug use were insensitive in identifying women who had positive drug screening results (sensitivity, 6.3 percent; specificity, 98.2 percent). Thus, in this study,the use of illicit drugs among women of childbearing age attending public clinics in Alabama was common and emphasizes the need for targeted drug education and interventions to reduce the impact of drug use on this high-risk population.
据估计,美国每年有35万至73.9万婴儿在子宫内接触到一种或多种非法药物。为了估计阿拉巴马州育龄妇女使用非法药物的患病率及风险因素,作者于1991年的2个月时间里,收集了该州6195名在公共卫生产科诊所、计划生育诊所及一家高危转诊产科诊所就诊的妇女的患者自述病史、临床病史及尿液样本。使用荧光偏振免疫分析法对尿液样本进行大麻、可卡因、阿片类药物、巴比妥类药物及苯丙胺类药物的盲法药物筛查。所检测药物阳性结果的总体患病率为10.1%,其中接受筛查的3554名孕妇中有8.4%呈阳性,2571名非孕妇中有12.3%呈阳性。最常检测到的药物是大麻和可卡因。与任何检测药物或大麻阳性结果患病率较高相关的受试者特征包括白人种族、年龄较大、离异、非学生职业、受教育年限为12年或以下、在郊区县的诊所就诊、自述有药物使用情况、感染人类免疫缺陷病毒的风险增加以及生殖史。可卡因筛查结果呈阳性的女性特征与任何药物检测呈阳性者相似,只是可卡因在黑人女性及在城市县诊所就诊者中的患病率较高,且不随受教育年限而变化。患者自述的药物使用病史在识别药物筛查结果呈阳性的女性方面不敏感(敏感性为6.3%;特异性为98.2%)。因此,在本研究中,阿拉巴马州在公共诊所就诊的育龄妇女中非法药物的使用很普遍,这凸显了开展有针对性的药物教育和干预措施以减少药物使用对这一高危人群影响的必要性。